VR Logo

InspireMD Inc. (NSPR) download report


Healthcare | Medical Devices & Equipment

InspireMD Inc. (NSPR) Premium Coverage

52 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: InspireMD, Inc., a medical device company, focuses on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East, and Asia Pacific.

IPO Date: 12-Apr-2011

Pres, CEO & Director: Mr. Marvin L. Slosman

CFO, Chief Admin. Officer, Sec. & Treasurer: Mr. Craig Shore

Listing: NASDAQ: NSPR

Country: Israel

Headquarters: Tel Aviv,

Website: https://www.inspiremd.com

Key Facts

Market cap: $16.98 Mln

Revenue (TTM): $4.67 Mln

Earnings (TTM): $-16.16 Mln

Cash: $29.85 Mln

Total Debt: $1.09 Mln

Insider's Holding: 9.19%

Liquidity: Low

52 Week range: $1.80 - 6.82

Shares outstanding: 8,323,200

10 Years Aggregate:

  • CFO: $-92.61 Mln
  • EBITDA: $-122.39 Mln
  • Net Profit: $-131.42 Mln

Stock Performance

Time Period InspireMD (NSPR) S&P BSE Sensex* S&P Small-Cap 600*
YTD-31.46-8.99-17.14
1 month1.47-3.40-4.85
3 months-34.70-7.57-12.74
1 Year-62.090.17-16.37
3 Years-66.2810.237.97
5 Years-65.0611.366.33
10 Years-72.1112.0710.54
As on 27-Jun-2022 *As on 28-Jun-2022
Year InspireMD (NSPR) S&P Small-Cap 600 S&P BSE Sensex
2021-40.7825.2721.99
2020-68.529.5715.75
2019-86.5020.8614.38
201822.94-9.705.87
2017-94.8011.7327.91
2016-88.6424.741.95
2015-88.72-3.36-5.03